THE PLACE FOR A NEW NATIONAL2MADE ΑΒ2BLOCKER, PROXODOLOL, IN THE TREATMENT OF HYPERTENSIVE CRISES

THE PLACE FOR A NEW NATIONAL2MADE ΑΒ2BLOCKER, PROXODOLOL, IN THE TREATMENT OF HYPERTENSIVE CRISES

A limited variety of hypotensive drugs is recommended for the treatment of I class hypertensive crises, requiring rapid action, high efficacy and having appropriate formulations available (sublingual or parenteral forms. Among β- blockers III generation drugs with additional vasodilative properties...

Full description

Bibliographic Details
Main Author:	M. V. Leonova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2002-10-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension crisis adrenoblockers
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1904

Similar Items

Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
by: S A Belyaeva, et al.
Published: (2011-04-01)

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)

B-ADRENOBLOCKERS IN THERAPY FOR ARTERIAL HYPERTENSION: ON THE WAY TO REASONABLE COMPROMISE
by: N B Perepech, et al.
Published: (2012-12-01)

Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities
by: N. G. Pivonova, et al.
Published: (2009-08-01)

DIURETIC-BASED COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION: RESULTS OF THE RUSSIAN TRUST STUDY
by: N. E. Gavrilova, et al.
Published: (2013-08-01)

EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE
by: S. A. Smakotina, et al.
Published: (2016-01-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01)

Bisoprolol effectiveness in arterial hypertension and coronary heart disease
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

BETA-ADRENOBLOCKERS IN LONG-TERM MONOTHERAPY AMONG PATIENTS WITH ARTERIAL HYPERTENSION: EFFECTS ON QUALITY OF LIFE AND TREATMENT COMPLIANCE
by: F. Z. Kasumova
Published: (2010-10-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
by: V. I. Makolkin
Published: (2016-01-01)

Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
by: V. B. Mychka
Published: (2012-06-01)

ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS: AN INDIVIDUALIZED CHOICE OF ANTIHYPERTENSIVE MEDICATIONS
by: T. E. Morozova, et al.
Published: (2011-04-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
by: R. I. Striuk, et al.
Published: (2015-12-01)

ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES
by: E. I. Bambysheva, et al.
Published: (2016-01-01)

Use of alpha-adrenoblockers intherapy of benign prostatic hyperplasia in patients with arterial hypertension
by: E В Mazo, et al.
Published: (2004-03-01)

Microcirculation in arterial hypertension patients receiving beta-adrenoblockers
by: L. L. Kirichenko, et al.
Published: (2006-12-01)

IMPACT OF MODERN ANTIHYPERTENSION MEDICATIONS ON THE CENTRAL PRESSURE AND ARTERIAL RIGIDITY
by: L. I. Gusakovskaya, et al.
Published: (2015-10-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
by: M. G. Bubnova
Published: (2008-12-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Risk of cardiovascular complications in patients with frequent hypertensive crises
by: Igor' Petrovich Kolos, et al.
Published: (2009-09-01)

Antihypertensive therapy and left ventricular hypertrophy prevention in patients with essential arterial hypertension and high treatment compliance
by: N. A. Koziolova, et al.
Published: (1970-01-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

ASCOT study: consequences and lessons
by: S. A. Boytsov
Published: (2007-12-01)

Pharmacoepidemiological Beta-blockers consumer research in Ukraine
by: O. Ya. Mishchenko, et al.
Published: (2012-12-01)

The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008
by: Irina Evgen'evna Chazova, et al.
Published: (2009-03-01)

USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES
by: V. R. Abdrakhmanov, et al.
Published: (2015-09-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study
by: T V Martyniuk, et al.
Published: (2012-12-01)

Status and function of betaDadrenoreceptors and their modification during betaDblocker treatment in patients with arterial hypertension and chronic heart failure
by: O. A. Maneshina, et al.
Published: (2005-10-01)

TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE
by: Michel Burnier, et al.
Published: (2010-04-01)

HYPERTENSIVE ENCEPHALOPATHY: BETWEEN DIAGNOSTIC ERROR AND REALITY
by: D. Cuciureanu
Published: (2007-09-01)

Modern opportunities of monotherapy in patients with arterial hypertension associated with comorbid disorders
by: G N Gorokhovskaya, et al.
Published: (2014-09-01)

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01)

Evaluation and treatment of hypertensive crises in children
by: Stein DR, et al.
Published: (2016-03-01)

THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015-09-01)

Cannot write session to /tmp/vufind_sessions/sess_qrqlvfa43ptcrrnqec7vd138u0